Lantern Pharma Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
Go back to Lantern Pharma Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates| (NASDAQ: LTRN) | Delayed: 3.88 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.88 | 52 Week High | $ | |||
| Open | $3.88 | 52 Week Low | $ | |||
| Day High | $3.88 | P/E | N/A | |||
| Day Low | $3.88 | EPS | $ | |||
| Volume | 209 | |||||

